MedPath

Stent-protected angioplasty in asymptomatic carotid artery stenosis vs endarterectomy: two two-arm clinical trials

Not Applicable
Completed
Conditions
Asymptomatic moderate to severe stenosis of the extracranial carotid artery
Circulatory System
Cerebrovascular diseases
Registration Number
ISRCTN78592017
Lead Sponsor
German Research Council (Deutsche Forschungsgemeinschaft [DFG]) (Germany)
Brief Summary

2009 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/19689759 protocol 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27085660 results 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/30873912/ results (added 04/08/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36115360/ (added 20/09/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
513
Inclusion Criteria

Sonographic identification of a more than or equal to 50% stenosis (North American Symptomatic Carotid Endarterectomy Trial [NASCET] criteria) of the extracranial carotid artery in a patient (both genders, age limit 85 years) without symptoms attributable to the target stenosis within the previous 180 days.

Exclusion Criteria

Non-atherosclerotic origin of carotid stenosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Cumulative rate of events consisting of:<br> 1. Any stroke within 30 days of treatment<br> 2. Death from any cause within 30 days<br> 3. Ipsilateral ischaemic stroke within five years<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. All single components of the primary endpoint clusters<br> 2. Any stroke, vascular death or myocardial infarction within 30 days (five years)<br> 3. Any ischaemic stroke within 30 days (five years)<br> 4. Disabling stroke within 30 days (five years)<br> 5. Technical failure of intervention<br> 6. Rate of re-stenosis (NASCET more than or equal to 50%)<br> 7. Rate of myocardial infarction (30 days)<br>
© Copyright 2025. All Rights Reserved by MedPath